Back to Search
NEIL SENZER, MD
MD
Radiation Oncology Physician
NPI: 1255379236Individual
Specialties, Licenses & Credentials
Research & Publications (20)
A review of contusugene ladenovec (Advexin) p53 therapy.
PMID 19169960·Curr Opin Mol Ther·2009
6-review
Individualised cancer therapeutics: dream or reality?
PMID 16300470·Expert Opin Ther Targets·2005
6-review
Irofulven demonstrates clinical activity against metastatic hormone-refractory prostate cancer in a phase 2 single-agent trial.
PMID 15685033·Am J Clin Oncol·2005
3-trial
TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors.
PMID 14726502·J Clin Oncol·2004
3-trial
A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findings.
PMID 12577242·Semin Oncol·2002
3-trial
Rationale for a phase III study of erythropoietin as a neurocognitive protectant in patients with lung cancer receiving prophylactic cranial irradiation.
PMID 12577244·Semin Oncol·2002
6-review
Systemic therapeutic gene delivery for cancer: crafting Paris' arrow.
PMID 19275571·Curr Gene Ther·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3410 WORTH ST
DALLAS, TX 75246 - Phone
- (214) 370-1400
Quick Facts
- NPI
- 1255379236
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile